Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Wireless Sweat Patch Could Be Used as Diagnostic Test for Cystic Fibrosis

By LabMedica International staff writers
Posted on 21 Aug 2025

Cystic fibrosis (CF) is a genetic disease that causes excessive mucus to accumulate in the lungs, impairs digestion, and can affect multiple organs. More...

More than 40,000 children and adults in the U.S. currently live with the disease, which is progressive and often results in early mortality. While treatments exist to improve quality of life, optimizing the use of new drugs outside clinical settings remains a challenge. A new wearable device now offers a way to monitor CF patients more effectively and provide real-time insights into treatment efficacy.

Developed by researchers from Northwestern Medicine (Chicago, IL, USA) in collaboration with spinout company Epicore Biosystems (Cambridge, MA, USA), the CF patch is a wireless sticker-like device that measures biomarkers in sweat. The patch is worn on the wrist and includes two channels: one for measuring sweat volume and another for measuring sweat chloride, the key diagnostic marker of CF. Physicians capture an image of the patch using a smartphone or tablet, and color changes are analyzed to provide data comparable in accuracy to laboratory-based testing.

In a study published in the Proceedings of the National Academy of Sciences, researchers evaluated the patch’s accuracy against the gold-standard chloride sweat test. To test feasibility, 20 adults with cystic fibrosis and seven healthy controls completed both a clinic-based chloride sweat test and five remote exercise sessions over 14 days while wearing the device. Researchers found that the CF patch measured sweat chloride as effectively as tests done in specialized laboratories.

These findings demonstrate that the wearable microfluidic sweat patch can deliver accurate, remote monitoring of sweat chloride in individuals with CF. Such technology could optimize the use of CFTR (cystic fibrosis transmembrane conductance regulator) modulator drugs, which improve protein function and disease trajectory, by offering consistent data on treatment effectiveness. The next phase will assess whether the device can guide clinical decision-making more directly in patient care.

Going forward, the patch could expand CF screening and monitoring in rural and under-resourced areas with limited access to diagnostic labs. By providing reliable results outside clinical environments, the device has the potential to expedite diagnosis and improve long-term disease management.

“We wanted to see how accurate our CF patch was relative to the gold standard, whether we could do it remotely at home, and then also see how consistent the sweat chloride is in response to the medications (i.e., CFTR modulators),” said Manu Jain, MD, senior author of the study. “Potentially this could be used as a screening or diagnostic test in parts of the country where sweat testing is not readily available and could expedite the diagnosis of cystic fibrosis.”

Related Links:
Northwestern Medicine
Epicore Biosystems


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Collection and Transport System
PurSafe Plus®
Human Estradiol Assay
Human Estradiol CLIA Kit
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: Automated cell imaging discriminates CD8+ T cells according to natalizumab treatment outcome in MS patients (B Chaves et al., Nat Commun 16, 5533 (2025). DOI: 10.1038/s41467-025-60224-3)

Novel Tool Predicts Most Effective Multiple Sclerosis Medication for Patients

Multiple sclerosis (MS) is a chronic autoimmune and degenerative neurological disease that affects the central nervous system, leading to motor, cognitive, and mental impairments. Symptoms can include... Read more

Industry

view channel
Image: ELITechGroup’s unique Real-Time PCR technologies include the revolutionary Minor Groove Binder (Photo courtesy of ELITechGroup)

ELITech and Hitachi High-Tech to Develop Automated PCR Testing System for Infectious Diseases

Molecular testing has become central to diagnosing and monitoring infectious diseases by analyzing genetic information. The use of PCR during the COVID-19 pandemic showed its value, but traditional systems... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.